Vascular endothelium as 'novel' target of graft-versus-host disease

Best Practice and Research: Clinical Haematology

Volumn 21, Issue 2, 2008, Pages 139-148

  Tichelli, André ^a   Gratwohl, Alois ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

allogeneic stem cell transplantation; cardiovascular; endothelial injury; graft versus host disease (GvHD)

Indexed keywords

ALPHA INTERFERON; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 8; BUSULFAN; CORTICOSTEROID; CYCLOSPORIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GEMTUZUMAB OZOGAMICIN; GRANULOCYTE COLONY STIMULATING FACTOR; INTERCELLULAR ADHESION MOLECULE 1; METHOTREXATE; MYCOPHENOLIC ACID; RAPAMYCIN; TACROLIMUS; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ABDOMINAL RADIOTHERAPY; ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ATHEROSCLEROSIS; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CANCER SURVIVAL; CAPILLARY LEAK SYNDROME; CARDIOVASCULAR DISEASE; CHRONIC GRAFT VERSUS HOST DISEASE; CHRONIC MYELOID LEUKEMIA; CYTOTOXIC T LYMPHOCYTE; DYSLIPIDEMIA; ENDOTHELIUM INJURY; ENGRAFTMENT SYNDROME; GLUCOSE INTOLERANCE; GRAFT SURVIVAL; HUMAN; HYPERTENSION; IMMUNE RESPONSE; LIVER VENOOCCLUSIVE DISEASE; LUNG HEMORRHAGE; LYMPHOCYTE TRANSFUSION; LYMPHOCYTIC INFILTRATION; MICROANGIOPATHY; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; REVIEW; RISK FACTOR; T CELL DEPLETION; VASCULAR ENDOTHELIUM;

CAPILLARY LEAK SYNDROME; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; TRANSPLANTATION, HOMOLOGOUS;

EID: 44249084010     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.beha.2008.02.002     Document Type: Review

References (40)

1. Gratwohl A., Baldomero H., Schmid O., et al. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003. Bone Marrow Transplantation 36 (2005) 575-590
2. Gratwohl A, Baldomero H, Frauendorfer K, et al. Results of the EBMT activity survey 2005 on haematopoietic stem cell transplantation: focus on increasing use of unrelated donors. Bone Marrow Transplantation 0 AD;39:71-87.
3. Shlomchik W.D. Graft-versus-host disease. Nature Reviews. Immunology 7 (2007) 340-352
4. Massenkeil G., Nagy M., Neuburger S., et al. Survival after reduced-intensity conditioning is not inferior to standard high-dose conditioning before allogeneic haematopoietic cell transplantation in acute leukaemias. Bone Marrow Transplantation 36 (2005) 683-689
5. Biedermann B.C., Sahner S., Gregor M., et al. Endothelial injury mediated by cytotoxic T lymphocytes and loss of microvessels in chronic graft versus host disease. Lancet 359 (2002) 2078-2083
6. Dumler J.S., Beschorner W.E., Farmer E.R., et al. Endothelial-cell injury in cutaneous acute graft-versus-host disease. American Journal of Pathology 135 (1989) 1097-1103
7. Shulman H.M., Sullivan K.M., Weiden P.L., et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. The American Journal of Medicine 69 (1980) 204-217
8. Sviland L., Sale G.E., and Myerson D. Endothelial changes in cutaneous graft-versus-host disease: a comparison between HLA matched and mismatched recipients of bone marrow transplantation. Bone Marrow Transplantation 7 (1991) 35-38
9. Ruutu T., Barosi G., Benjamin R.J., et al. Diagnostic criteria for hematopoietic stem cell transplant-associated microangiopathy: results of a consensus process by an International Working Group. Haematologica 92 (2007) 95-100
10. Shimoni A., Yeshurun M., Hardan I., et al. Thrombotic microangiopathy after allogeneic stem cell transplantation in the era of reduced-intensity conditioning: the incidence is not reduced. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 10 (2004) 484-493
11. Uderzo C., Bonanomi S., Busca A., et al. Risk factors and severe outcome in thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation. Transplantation 82 (2006) 638-644
12. McDonald G.B., Hinds M.S., Fisher L.D., et al. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients. Annals of Internal Medicine 118 (1993) 255-267
13. Carreras E., Bertz H., Arcese W., et al. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party. Blood 92 (1998) 3599-3604
14. Cheuk D.K., Wang P., Lee T.L., et al. Risk factors and mortality predictors of hepatic veno-occlusive disease after pediatric hematopoietic stem cell transplantation. Bone Marrow Transplantation (2007)
15. Majhail N.S., Parks K., Defor T.E., et al. Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 12 (2006) 1038-1046
16. Wojno K.J., Vogelsang G.B., Beschorner W.E., et al. Pulmonary hemorrhage as a cause of death in allogeneic bone marrow recipients with severe acute graft-versus-host disease. Transplantation 57 (1994) 88-92
17. Spitzer T.R. Engraftment syndrome following hematopoietic stem cell transplantation. Bone Marrow Transplantation 27 (2001) 893-898
18. Gorak E., Geller N., Srinivasan R., et al. Engraftment syndrome after nonmyeloablative allogeneic hematopoietic stem cell transplantation: incidence and effects on survival. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 11 (2005) 542-550
19. Colby C., McAfee S., Sackstein R., et al. Engraftment syndrome following myeloablative conditioning therapy and HLA-matched bone marrow transplantation (BMT) for hematological malignancy. Blood 96 (2000) 520a
20. Deeren D.H., Zachee P., and Malbrain M.L. Granulocyte colony-stimulating factor-induced capillary leak syndrome confirmed by extravascular lung water measurements. Annals of Hematology 84 (2005) 89-94
21. Nurnberger W., Willers R., Burdach S., et al. Risk factors for capillary leakage syndrome after bone marrow transplantation. Annals of Hematology 74 (1997) 221-224
22. Gyger M., Rosenberg A., Shamy A., et al. Vascular leak syndrome and serositis as an unusual manifestation of chronic graft-versus-host disease in nonmyeloablative transplants. Bone Marrow Transplantation 35 (2004) 201-203
23. Cahill R.A., Spitzer T.R., and Mazumder A. Marrow engraftment and clinical manifestations of capillary leak syndrome. Bone Marrow Transplantation 18 (1996) 177-184
24. Talvensaari K.K., Lanning M., Tapanainen P., et al. Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. The Journal of Clinical Endocrinology and Metabolism 81 (1996) 3051-3055
25. Boivin J.F., Hutchison G.B., Lubin J.H., et al. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 69 (1992) 1241-1247
26. Taskinen M., Saarinen-Pihkala U.M., Hovi L., et al. Impaired glucose tolerance and dyslipidaemia as late effects after bone-marrow transplantation in childhood. Lancet 356 (2000) 993-997
27. Baker K.S., Ness K.K., Steinberger J., et al. Diabetes, hypertension and cardiovascular events in survivors of hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Blood 109 (2007) 1765-1772
28. Couriel D.R., Saliba R., Escalon M.P., et al. Sirolimus in combination with tacrolimus and corticosteroids for the treatment of resistant chronic graft-versus-host disease. British Journal of Haematology 130 (2005) 409-417
29. Tichelli A., Bucher C., Rovo A., et al. Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. Blood 110 (2007) 3463-3471
30. Kapadia S.R., Ziada K.M., L'Allier P.L., et al. Intravascular ultrasound imaging after cardiac transplantation: advantage of multi-vessel imaging. The Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 19 (2000) 167-172
31. Rahmani M., Cruz R.P., Granville D.J., et al. Allograft vasculopathy versus atherosclerosis. Circulation Research 99 (2006) 801-815
32. Kasiske B.L., Guijarro C., Massy Z.A., et al. Cardiovascular disease after renal transplantation. Journal of the American Society of Nephrology 7 (1996) 158-165
33. Cailhier J.F., Laplante P., and Hebert M.J. Endothelial apoptosis and chronic transplant vasculopathy: recent results, novel mechanisms. American Journal of Transplantation: Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons 6 (2006) 247-253
34. Wojcik D., Socié G., Rapala M., et al., on behalf of the EBMT Late Effect Working Party. Late vascular complications after haematopoietic stem cell transplantation: a retrospective multicentre study of the Late Effect Working Party EBMT. Bone Marrow Transplantation 37 Suppl. 1 (March 2006) 269
35. Tesfamariam B., and DeFelice A.F. Endothelial injury in the initiation and progression of vascular disorders. Vascular Pharmacology 46 (2007) 229-237
36. Goon P.K., Boos C.J., and Lip G.Y. Circulating endothelial cells: markers of vascular dysfunction. Clinical Laboratory 51 (2005) 531-538
37. Pihusch V., Rank A., Steber R., et al. Endothelial cell-derived microparticles in allogeneic hematopoietic stem cell recipients. Transplantation 81 (2006) 1405-1409
38. Salat C., Holler E., Kolb H.J., et al. Endothelial cell markers in bone marrow transplant recipients with and without acute graft-versus-host disease. Bone Marrow Transplantation 19 (1997) 909-914
39. Biedermann B.C., Tsakiris D.A., Gregor M., et al. Combining altered levels of effector transcripts in circulating T cells with a marker of endothelial injury is specific for active graft-versus-host disease. Bone Marrow Transplantation 32 (2003) 1077-1084
40. Matsuda Y., Hara J., Osugi Y., et al. Serum levels of soluble adhesion molecules in stem cell transplantation-related complications. Bone Marrow Transplantation 27 (2001) 977-982